Skip to main content
Premium Trial:

Request an Annual Quote

DiamiR Biosciences, JADBio Partner on Machine Learning for Assay Development

NEW YORK – DiamiR Biosciences and JADBio said Wednesday that they have inked an agreement to develop predictive models of Alzheimer's disease and Rett syndrome.

The agreement, the financial details of which were not disclosed, grants DiamiR the use of JADBio's Automated Machine Learning (AutoML) Platform and services, which will be used in conjunction with DiamiR's microRNA panels.

"Applying machine learning capabilities to our microRNA platform is a key step towards validation of our diagnostic tests," Alidad Mireskandari, DiamiR's CEO, said in a statement.

DiamiR previously won two National Institutes of Health grants totaling nearly $3.9 million to support the development of its microRNA panels for mild cognitive impairment, Alzheimer's disease, and the rare neurological disorder Rett syndrome; to assess the feasibility of differentiating Rett syndrome from age-matched controls; and to determine whether circulating miRNAs can be used to predict disease severity and monitor disease progression.

"We are thrilled to be partnering with DiamiR, as we are confident that our state-of-the-art ML platform and services will prove instrumental in DiamiR's efforts to efficiently validate their biomarker panels and develop highly accurate diagnostic tests," JADBio CEO Pavlos Charonyktakis said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.